Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease
Evelyn Ullrich, … , Markus F. Neurath, Kai Hildner
Evelyn Ullrich, … , Markus F. Neurath, Kai Hildner
Published January 29, 2018
Citation Information: J Clin Invest. 2018;128(3):916-930. https://doi.org/10.1172/JCI89242.
View: Text | PDF
Research Article Gastroenterology Immunology

BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease

  • Text
  • PDF
Abstract

Acute graft-versus-host disease (GVHD) represents a severe, T cell–driven inflammatory complication following allogeneic hematopoietic cell transplantation (allo-HCT). GVHD often affects the intestine and is associated with a poor prognosis. Although frequently detectable, proinflammatory mechanisms exerted by intestinal tissue–infiltrating Th cell subsets remain to be fully elucidated. Here, we show that the Th17-defining transcription factor basic leucine zipper transcription factor ATF-like (BATF) was strongly regulated across human and mouse intestinal GVHD tissues. Studies in complete MHC-mismatched and minor histocompatibility–mismatched (miHA-mismatched) GVHD models revealed that BATF-expressing T cells were functionally indispensable for intestinal GVHD manifestation. Mechanistically, BATF controlled the formation of colon-infiltrating, IL-7 receptor–positive (IL-7R+), granulocyte-macrophage colony-stimulating factor–positive (GM-CSF+), donor T effector memory (Tem) cells. This T cell subset was sufficient to promote intestinal GVHD, while its occurrence was largely dependent on T cell–intrinsic BATF expression, required IL-7–IL-7R interaction, and was enhanced by GM-CSF. Thus, this study identifies BATF-dependent pathogenic GM-CSF+ effector T cells as critical promoters of intestinal inflammation in GVHD and hence putatively provides mechanistic insight into inflammatory processes previously assumed to be selectively Th17 driven.

Authors

Evelyn Ullrich, Benjamin Abendroth, Johanna Rothamer, Carina Huber, Maike Büttner-Herold, Vera Buchele, Tina Vogler, Thomas Longerich, Sebastian Zundler, Simon Völkl, Andreas Beilhack, Stefan Rose-John, Stefan Wirtz, Georg F. Weber, Sakhila Ghimire, Marina Kreutz, Ernst Holler, Andreas Mackensen, Markus F. Neurath, Kai Hildner

×

Figure 8

BATF controls the formation of IL-7RhiGM-CSF+ T cells.

Options: View larger image (or click on image) Download as PowerPoint
BATF controls the formation of IL-7RhiGM-CSF+ T cells.
(A) GM-CSF+CD4+ T...
(A) GM-CSF+CD4+ T cell frequencies by intracellular flow cytometry on day 5 of in vitro culture under IFN-γ–neutralizing conditions, with or without IL-7. Bar graph represents pooled data from 4 independent experiments and indicates the mean ± SEM. Without IL-7 (–), n = 10 WT and n = 7 Batf–/– mice; with IL-7 (+), n = 16 WT and n = 12 Batf–/– mice. (B) GM-CSF–expressing, donor-derived CD45.2+CD3+CD4+ cLP T cell frequencies ex vivo in GVHD-prone mice after WT and Batf–/– CD3+ donor T cell transfer (C57Bl/6 into BALB/c). Bar graph indicates the mean ± SEM of 4 individual mice per group from 1 experiment. (C and D) Flow cytometric contour plots display IL-7R and GM-CSF levels of (C) MLN (day 15), cLP (days 15 and 28), and (D) cLP (day 27) donor-derived CD4+ T cells after GVHD induction by C57Bl/6 WT (red) and Batf–/– (black) CD3+ T cell transfer into (C) BALB/c and (D) BALB.b mice, respectively. Histograms show the IL-7R expression status of GM-CSF+CD45.2+CD4+ T cells compared with IL-7R isotype control staining (gray-shaded area). Mean values ± SEM represent frequencies (top) and absolute numbers of IL-7RhiGM-CSF+ cells within CD45.2+CD4+ donor T cells found in the MLN (C) and cLP (C, days 15 and 28; D, day 27). Results for WT mice (C, MLN and cLP, day 15: n = 7; cLP, day 28: n = 7; D, n = 4) and Batf–/– mice (C, MLN and cLP, day 15: n = 7; cLP, day 28: n = 4; D, n = 5) from 1 of 2 experiments are shown. (E) Relative frequencies and absolute numbers of CD45.2+CD3+CD4+IL-7RhiCD44+CD62L– cLP T cells (Tem cells) of the indicated genotypes 28 days after GVHD induction (C57Bl/6 into BALB/c), as described in B, were assessed by flow cytometry. Bar graphs indicate the mean ± SEM (n = 7 WT mice and n = 4 Batf–/– mice). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by 1-way ANOVA with Bonferroni’s multiple comparisons post test (A and B) and unpaired Student’s t test (C–E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts